Objectives To implement non‐invasive prenatal testing (NIPT) for fetal aneuploidies with
semiconductor sequencing in an academic cytogenomic laboratory and to evaluate the first …

Background This paper describes the clinical practice and performance of cell-free DNA
sequencing-based non-invasive prenatal testing (NIPT) as a screening method for fetal …

Noninvasive prenatal testing (NIPT) represents an outstanding example of how novel
scientific discoveries can be quickly and successfully developed into hugely impactful …

IntroductionNon-invasive prenatal testing (NIPT) using cell-free foetal DNA has been widely
accepted in recent years for detecting common foetal chromosome aneuploidies, such as …

Objective Here we describe the successful application of massively parallel sequencing for
noninvasive prenatal detection of trisomy 21. In addition, for the detection of a broader …

Noninvasive prenatal testing (NIPT) for fetal aneuploidies using cell-free fetal DNA in
maternal plasma has revolutionized the field of prenatal care and methods using massively …

Objective The objective of this study was to introduce non‐invasive prenatal testing (NIPT)
for fetal autosomal trisomies and gender in a Danish public health setting, using semi …

Objectives We have established an open source platform for non-invasive prenatal testing
(NIPT) based on massively parallel whole-genome sequencing in a public setting. The …

Purpose Noninvasive prenatal testing (NIPT) is a highly sensitive and specific method for
detection of fetal chromosomal aneuploidies from maternal plasma. The objective of this …

Noninvasive prenatal testing by massive parallel sequencing of maternal plasma DNA has
rapidly been adopted as a mainstream method for detection of fetal trisomy 21, 18 and 13 …